Shuang Chen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Human Immunodeficiency Virus

Endothelial Cells

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Richard Hong, Haichen Nie, Rodger F Henry, Sean M Garner, Nathaniel D Catron, Russell L Hertzler, Andrew J Souers, Ahmad Y Sheikh, Shuang Chen
Pharmaceutical Development Challenges in a Beyond Rule of Five Prodrug: Case Study of ABBV-167, Phosphate Prodrug of Venetoclax. Molecular pharmaceutics (2023)
Shuang Chen, Yi Gao, Xiaochun Lou, Rodger F Henry, DeAnne F Stolarik, Maya P Lipert, Ahmad Y Sheikh, Geoff G Z Zhang
Overcoming Bioavailability Challenges of Dasabuvir and Enabling a Triple-Combination Direct-Acting Antiviral HCV Regimen through a Salt of Very Weak Acid for Oral Delivery. Molecular pharmaceutics 19 (7) (2022)